166 related articles for article (PubMed ID: 20354780)
1. Inhibition of focal adhesion kinase suppresses the adverse phenotype of endocrine-resistant breast cancer cells and improves endocrine response in endocrine-sensitive cells.
Hiscox S; Barnfather P; Hayes E; Bramble P; Christensen J; Nicholson RI; Barrett-Lee P
Breast Cancer Res Treat; 2011 Feb; 125(3):659-69. PubMed ID: 20354780
[TBL] [Abstract][Full Text] [Related]
2. Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells.
Hiscox S; Morgan L; Green TP; Barrow D; Gee J; Nicholson RI
Breast Cancer Res Treat; 2006 Jun; 97(3):263-74. PubMed ID: 16333527
[TBL] [Abstract][Full Text] [Related]
3. Targeting focal adhesion kinase in ER+/HER2+ breast cancer improves trastuzumab response.
Lazaro G; Smith C; Goddard L; Jordan N; McClelland R; Barrett-Lee P; Nicholson RI; Hiscox S
Endocr Relat Cancer; 2013 Oct; 20(5):691-704. PubMed ID: 23900794
[TBL] [Abstract][Full Text] [Related]
4. Dual targeting of Src and ER prevents acquired antihormone resistance in breast cancer cells.
Hiscox S; Jordan NJ; Smith C; James M; Morgan L; Taylor KM; Green TP; Nicholson RI
Breast Cancer Res Treat; 2009 May; 115(1):57-67. PubMed ID: 18493848
[TBL] [Abstract][Full Text] [Related]
5. TAE226-induced apoptosis in breast cancer cells with overexpressed Src or EGFR.
Golubovskaya VM; Virnig C; Cance WG
Mol Carcinog; 2008 Mar; 47(3):222-34. PubMed ID: 17849451
[TBL] [Abstract][Full Text] [Related]
6. Src kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells.
Hiscox S; Jordan NJ; Morgan L; Green TP; Nicholson RI
Clin Exp Metastasis; 2007; 24(3):157-67. PubMed ID: 17394086
[TBL] [Abstract][Full Text] [Related]
7. A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.
Shi Q; Hjelmeland AB; Keir ST; Song L; Wickman S; Jackson D; Ohmori O; Bigner DD; Friedman HS; Rich JN
Mol Carcinog; 2007 Jun; 46(6):488-96. PubMed ID: 17219439
[TBL] [Abstract][Full Text] [Related]
8. Evidence for activation of BK Ca channels by a known inhibitor of focal adhesion kinase, PF573228.
So EC; Wu KC; Liang CH; Chen JY; Wu SN
Life Sci; 2011 Nov; 89(19-20):691-701. PubMed ID: 21925512
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen treatment promotes phosphorylation of the adhesion molecules, p130Cas/BCAR1, FAK and Src, via an adhesion-dependent pathway.
Cowell LN; Graham JD; Bouton AH; Clarke CL; O'Neill GM
Oncogene; 2006 Dec; 25(58):7597-607. PubMed ID: 16799644
[TBL] [Abstract][Full Text] [Related]
10. Involvement of focal adhesion kinase in inhibition of motility of human breast cancer cells by sphingosine 1-phosphate.
Wang F; Nohara K; Olivera A; Thompson EW; Spiegel S
Exp Cell Res; 1999 Feb; 247(1):17-28. PubMed ID: 10047444
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271.
Roberts WG; Ung E; Whalen P; Cooper B; Hulford C; Autry C; Richter D; Emerson E; Lin J; Kath J; Coleman K; Yao L; Martinez-Alsina L; Lorenzen M; Berliner M; Luzzio M; Patel N; Schmitt E; LaGreca S; Jani J; Wessel M; Marr E; Griffor M; Vajdos F
Cancer Res; 2008 Mar; 68(6):1935-44. PubMed ID: 18339875
[TBL] [Abstract][Full Text] [Related]
12. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.
Behmoaram E; Bijian K; Jie S; Xu Y; Darnel A; Bismar TA; Alaoui-Jamali MA
Am J Pathol; 2008 Nov; 173(5):1540-50. PubMed ID: 18832579
[TBL] [Abstract][Full Text] [Related]
13. Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B.
Ko BS; Chang TC; Chen CH; Liu CC; Kuo CC; Hsu C; Shen YC; Shen TL; Golubovskaya VM; Chang CC; Shyue SK; Liou JY
Life Sci; 2010 Jan; 86(5-6):199-206. PubMed ID: 20006625
[TBL] [Abstract][Full Text] [Related]
14. Effect of triptolide on focal adhesion kinase and survival in MCF-7 breast cancer cells.
Tan BJ; Tan BH; Chiu GN
Oncol Rep; 2011 Nov; 26(5):1315-21. PubMed ID: 21805042
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of Yangzheng Xiaoji on angiogenesis and the role of the focal adhesion kinase pathway.
Jiang WG; Ye L; Ji K; Frewer N; Ji J; Mason MD
Int J Oncol; 2012 Nov; 41(5):1635-42. PubMed ID: 22971748
[TBL] [Abstract][Full Text] [Related]
16. Analysis of phosphorylation sites on focal adhesion kinase using nanospray liquid chromatography/multiple reaction monitoring mass spectrometry.
Ciccimaro E; Hevko J; Blair IA
Rapid Commun Mass Spectrom; 2006; 20(24):3681-92. PubMed ID: 17117420
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation.
Hiscox S; Jiang WG; Obermeier K; Taylor K; Morgan L; Burmi R; Barrow D; Nicholson RI
Int J Cancer; 2006 Jan; 118(2):290-301. PubMed ID: 16080193
[TBL] [Abstract][Full Text] [Related]
18. Expression of MLN64 influences cellular matrix adhesion of breast cancer cells, the role for focal adhesion kinase.
Cai W; Ye L; Sun J; Mansel RE; Jiang WG
Int J Mol Med; 2010 Apr; 25(4):573-80. PubMed ID: 20198306
[TBL] [Abstract][Full Text] [Related]
19. Disruption of focal adhesion kinase slows transendothelial migration of AU-565 breast cancer cells.
Earley S; Plopper GE
Biochem Biophys Res Commun; 2006 Nov; 350(2):405-12. PubMed ID: 17010315
[TBL] [Abstract][Full Text] [Related]
20. Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts.
Schwock J; Dhani N; Cao MP; Zheng J; Clarkson R; Radulovich N; Navab R; Horn LC; Hedley DW
Cancer Res; 2009 Jun; 69(11):4750-9. PubMed ID: 19458065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
